OmniAb Q2 revenue beats analyst estimates, outlook raised

OmniAB

06/08/2026 21:40

Overview
US discovery research tech firm's Q2 revenue rose sharply, beating analyst expectations
Net loss for Q2 narrowed compared to same period last year
Company raised full-year 2026 revenue and cash outlook on continued business momentum

Outlook
OmniAb raises 2026 revenue outlook to $32 mln-$36 mln from $28 mln-$33 mln
Company now expects 2026 year-end cash and equivalents of $37 mln-$41 mln, up from $33 mln-$38 mln
OmniAb sees 2026 costs and operating expenses at $84 mln-$88 mln, slightly above prior forecast

Result Drivers
MILESTONE REVENUE - Co said Q2 revenue increase was driven primarily by milestone revenue
NEW PROGRAMS AND SALES - Service revenue rose due to commencement of new ion channel programs, and xPloration revenue increased on higher instrument and consumable sales
PARTNER PROGRAM ADVANCEMENTS - Co cited recent updates from partner programs and new license agreements as supporting business momentum

Company press release: ID:nBwCL9gLa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$13.4 mln
$4.69 mln (7 Analysts)
Q2 Loss Per Share
 
$0.05
 
Q2 Net Loss
 
$5.9 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy"
Wall Street's median 12-month price target for OmniAb Inc is $8.00, about 294.1% above its August 5 closing price of $2.03

Reuters Recommended Reads
Aug 5 - Charles River lifts profit forecast on improving biotech demand
Aug 5 - AbCellera Q2 net loss widens on higher expenses
Aug 5 - Schrodinger Q2 revenue beats estimates, swings to profit

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)